The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.A total of 169,891 patients in Peking Union Medical College Hospi...
Saved in:
Published in | Frontiers in immunology Vol. 13; p. 1007257 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
27.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People's Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.MethodsA total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People's Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.The positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.ResultsThe positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.The RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification.ConclusionThe RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification. |
---|---|
AbstractList | To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People's Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.MethodsA total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People's Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.The positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.ResultsThe positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.The RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification.ConclusionThe RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification. ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.MethodsA total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People’s Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively.ResultsThe positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody.ConclusionThe RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification. |
Author | Meng, Jingjing Deng, Chuiwen Song, Ning Luo, Yueming Yang, Guoxiang Li, Mengtao Bai, Yina Zeng, Xiaofeng Li, Siting Hu, Chaojun |
AuthorAffiliation | 2 Department of Clinical Laboratory, Fifth Affiliated Hospital of Zhengzhou University , Zhengzhou , China 3 Department of Clinical Laboratory, Inner Mongolia People’s Hospital , Hohhot , China 4 Jiangmen Wuyi Hospital of Traditional Chinese Medicine (TCM) (Affiliated Jiangmen TCM Hospital of Ji’nan University) , Jiangmen , China 1 Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education , Beijing , China |
AuthorAffiliation_xml | – name: 2 Department of Clinical Laboratory, Fifth Affiliated Hospital of Zhengzhou University , Zhengzhou , China – name: 3 Department of Clinical Laboratory, Inner Mongolia People’s Hospital , Hohhot , China – name: 1 Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education , Beijing , China – name: 4 Jiangmen Wuyi Hospital of Traditional Chinese Medicine (TCM) (Affiliated Jiangmen TCM Hospital of Ji’nan University) , Jiangmen , China |
Author_xml | – sequence: 1 givenname: Jingjing surname: Meng fullname: Meng, Jingjing – sequence: 2 givenname: Guoxiang surname: Yang fullname: Yang, Guoxiang – sequence: 3 givenname: Siting surname: Li fullname: Li, Siting – sequence: 4 givenname: Yueming surname: Luo fullname: Luo, Yueming – sequence: 5 givenname: Yina surname: Bai fullname: Bai, Yina – sequence: 6 givenname: Chuiwen surname: Deng fullname: Deng, Chuiwen – sequence: 7 givenname: Ning surname: Song fullname: Song, Ning – sequence: 8 givenname: Mengtao surname: Li fullname: Li, Mengtao – sequence: 9 givenname: Xiaofeng surname: Zeng fullname: Zeng, Xiaofeng – sequence: 10 givenname: Chaojun surname: Hu fullname: Hu, Chaojun |
BookMark | eNp9kk1vGyEQhldVKjVN8wd64tiL3eVrd-mhUmT1I1KkXtIzYmGwiVhwgXWVH9H_XNa2oqSHcmE0zDwvDO_b5iLEAE3zHrdrSgfx0bppmtekJWSN27YnvH_VXOKuYytKCLt4Fr9prnN-aOtiglLKL5s_9ztA2rvgtPLooPwMKFrkgnEJdEELOkTr55ggawgakI0JZZ0AggtbpEJxqxRNrpFBqabyMTdG4yB_QjcoQUkx7yvNHQDlMpvHRaL8jqgCC6Rc5dBm54J617y2yme4Pu9Xzc-vX-4331d3P77dbm7uVpoxXlbAW8pGQbGxdsTGDIpRYYi2ZugU5ZZixYwmmCvRGz0yjY0WdT4UBOvEyOlVc3vimqge5D65SaVHGZWTx0RMW6lScdqDNMzynoy9Zf3AsLAK92NHBtsTGGlVqKzPJ9Z-Hicwy5OS8i-gL0-C28ltPEjBOSFYVMCHMyDFXzPkIidXR-29ChDnLEn9UTyIoW9rKTmV6jrRnMA-yeBWLl6QRy_IxQvy7IXaNPzTpF1RxcXlOs7_r_UvUITBNg |
CitedBy_id | crossref_primary_10_3389_fimmu_2024_1359030 |
Cites_doi | 10.1097/BOR.0000000000000834 10.23937/2469-5726/1510073 10.3389/fonc.2021.631038 10.1002/art.34380 10.1111/sji.12803 10.1186/s13317-020-00139-9 10.1111/j.1365-2036.2006.03172.x 10.1186/s13008-018-0038-0 10.1093/labmed/lmy024 10.1136/annrheumdis-2018-214436 10.1038/s41584-021-00573-7 10.1016/j.antiviral.2018.12.017 10.1007/s11882-013-0405-5 10.1007/s12016-018-8718-8 10.1016/j.critrevonc.2018.05.002 10.2174/138955709788452676 10.1111/sji.12848 10.3851/IMP1993 10.1186/1471-230X-13-50 10.1016/j.autrev.2021.102922 10.5114/reum.2018.77976 10.1016/B978-0-12-800097-7.00002-6 10.1034/j.1600-0676.2001.021004272.x 10.1111/pcmr.12854 10.1371/journal.pone.0045392 10.1016/j.cca.2021.07.006 10.15386/cjmed-996 10.1038/s41598-021-87366-w 10.1007/s12026-020-09136-6 10.3748/wjg.v22.i6.1966 10.3109/08916934.2015.1118762 10.1016/j.autrev.2019.102400 10.1111/jvh.12281 10.3389/fimmu.2020.562138 10.1002/cam4.4675 10.3389/fimmu.2015.00041 10.1016/j.jgg.2015.04.002 10.1515/cclm-2017-1152 10.1111/1348-0421.12879 10.1016/j.autrev.2011.06.005 10.1371/journal.pone.0185977 10.1016/j.autrev.2020.102643 10.1016/j.cca.2010.12.019 10.1080/23744235.2019.1690676 10.1007/s10875-012-9827-4 10.1016/j.transproceed.2004.09.070 10.1016/j.clim.2016.10.004 10.1089/vim.2019.0012 10.1369/0022155414543853 10.1007/s12026-014-8515-2 10.1016/j.yexcr.2017.10.030 10.1016/j.cca.2019.06.027 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu. Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu |
Copyright_xml | – notice: Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu. – notice: Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fimmu.2022.1007257 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
ExternalDocumentID | oai_doaj_org_article_d4f572b7f478419fa17b628f72eb315a PMC9552219 10_3389_fimmu_2022_1007257 |
GrantInformation_xml | – fundername: ; |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM 7X8 5PM |
ID | FETCH-LOGICAL-c445t-e5034b931dffb1dd8a439d2cfd86a35f31a4dc215a97dcb4c1dc92023e9469b53 |
IEDL.DBID | M48 |
ISSN | 1664-3224 |
IngestDate | Wed Aug 27 01:30:01 EDT 2025 Thu Aug 21 18:39:14 EDT 2025 Fri Jul 11 12:07:47 EDT 2025 Thu Apr 24 23:04:47 EDT 2025 Tue Jul 01 02:11:28 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c445t-e5034b931dffb1dd8a439d2cfd86a35f31a4dc215a97dcb4c1dc92023e9469b53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Markus Wilhelmi, Bürgerhospital Frankfurt, Germany; Mirjana Sefik Bukilica, Belgrade University, Serbia This article was submitted to Autoimmune and Autoinflammatory Disorders: Autoimmune Disorders, a section of the journal Frontiers in Immunology Edited by: Alessandro Granito, University of Bologna, Italy These authors have contributed equally to this work and share first authorship |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2022.1007257 |
PQID | 2725189870 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d4f572b7f478419fa17b628f72eb315a pubmedcentral_primary_oai_pubmedcentral_nih_gov_9552219 proquest_miscellaneous_2725189870 crossref_primary_10_3389_fimmu_2022_1007257 crossref_citationtrail_10_3389_fimmu_2022_1007257 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-09-27 |
PublicationDateYYYYMMDD | 2022-09-27 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-27 day: 27 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in immunology |
PublicationYear | 2022 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Im (B9) 2020; 52 Juda (B16) 2014; 62 Damoiseaux (B12) 2019; 78 Zhang (B38) 2019; 91 Zheng (B39) 2020; 11 Ma (B1) 2019; 496 Carcamo (B15) 2014; 308 Granito (B48) 2021; 17 Wang (B27) 2019; 90 Keppeke (B24) 2012; 7 Assandri (B45) 2019; 12 Calise (B13) 2015; 6 Dinse (B40) 2017; 12 da Silva Sacerdote (B31) 2020; 68 Carcamo (B20) 2013; 33 Keppeke (B22) 2016; 173 Katayama (B51) 2022; 21 Bogdanos (B44) 2021; 521 Barth (B6) 2022; 11 Calise (B25) 2018; 56 Novembrino (B35) 2014; 21 Keppeke (B54) 2020; 33 Chang (B53) 2017; 361 Vlagea (B4) 2018; 127 Feldrihan (B34) 2019; 92 Dhaouadi (B36) 2019; 32 Keppeke (B32) 2016; 22 Wang (B5) 2021; 11 Alsaed (B41) 2021; 11 Stochmal (B3) 2020; 58 Tiniakou (B2) 2021; 33 Sur (B8) 2018; 49 Op De Beeck (B11) 2011; 10 Peker (B33) 2021; 65 Van Hoovels (B29) 2020; 11 Assandri (B19) 2021; 14 Keppeke (B21) 2014; 60 Pisetsky (B28) 2019; 18 Grygiel-Gorniak (B10) 2018; 56 Keppeke (B52) 2018; 13 Keppeke (B50) 2019; 162 Granito (B46) 2006; 24 Stinton (B18) 2013; 13 Covini (B14) 2012; 17 Keppeke (B17) 2015; 42 Granito (B49) 2009; 9 Vannozzi (B43) 2004; 36 Satoh (B26) 2012; 64 Bhagat (B7) 2014; 14 Bogdanos (B47) 2011; 412 Magerl (B37) 2019; 5 Fox (B42) 2001; 21 Calise (B30) 2020; 19 Climent (B23) 2016; 49 |
References_xml | – volume: 33 year: 2021 ident: B2 article-title: Insights into origins and specificities of autoantibodies in systemic sclerosis publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000834 – volume: 5 year: 2019 ident: B37 article-title: ANA-Hep2 positive with anti-rods and rings pattern in a child without hepatitis c under treatment: Case report publication-title: J Rheumatic Dis Treat doi: 10.23937/2469-5726/1510073 – volume: 11 year: 2021 ident: B5 article-title: Antinuclear antibodies with a nucleolar pattern are associated with a significant reduction in the overall survival of patients with leukemia: A retrospective cohort study publication-title: Front Oncol doi: 10.3389/fonc.2021.631038 – volume: 64 year: 2012 ident: B26 article-title: Prevalence and sociodemographic correlates of antinuclear antibodies in the united states publication-title: Arthritis Rheum doi: 10.1002/art.34380 – volume: 90 start-page: e12803 year: 2019 ident: B27 article-title: Anti-centrosome antibodies: Prevalence and disease association in Chinese population publication-title: Scand J Immunol doi: 10.1111/sji.12803 – volume: 11 start-page: 17 year: 2020 ident: B29 article-title: Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey publication-title: Auto Immun Highlights doi: 10.1186/s13317-020-00139-9 – volume: 24 year: 2006 ident: B46 article-title: Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2006.03172.x – volume: 13 start-page: 5 year: 2018 ident: B52 article-title: IMP/GTP balance modulates cytoophidium assembly and IMPDH activity publication-title: Cell Div doi: 10.1186/s13008-018-0038-0 – volume: 49 year: 2018 ident: B8 article-title: Antinuclear antibodies: Marker of diagnosis and evolution in autoimmune diseases publication-title: Lab Med doi: 10.1093/labmed/lmy024 – volume: 78 year: 2019 ident: B12 article-title: Clinical relevance of HEp-2 indirect immunofluorescent patterns: the international consensus on ANA patterns (ICAP) perspective publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2018-214436 – volume: 17 start-page: 244 year: 2021 ident: B48 article-title: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-021-00573-7 – volume: 162 year: 2019 ident: B50 article-title: Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs publication-title: Antiviral Res doi: 10.1016/j.antiviral.2018.12.017 – volume: 14 start-page: 405 year: 2014 ident: B7 article-title: Utility of immunologic testing in suspected rheumatologic disease publication-title: Curr Allergy Asthma Rep doi: 10.1007/s11882-013-0405-5 – volume: 58 start-page: 40 year: 2020 ident: B3 article-title: Antinuclear antibodies in systemic sclerosis: an update publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-018-8718-8 – volume: 127 year: 2018 ident: B4 article-title: Antinuclear antibodies and cancer: A literature review publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2018.05.002 – volume: 9 year: 2009 ident: B49 article-title: Diagnosis and therapy of autoimmune hepatitis publication-title: Mini Rev Med Chem doi: 10.2174/138955709788452676 – volume: 91 year: 2019 ident: B38 article-title: The value of anti-rods and rings antibodies in Western China population: A retrospective study publication-title: Scandinavian J Immunol doi: 10.1111/sji.12848 – volume: 17 year: 2012 ident: B14 article-title: Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis c publication-title: Antivir Ther doi: 10.3851/IMP1993 – volume: 13 start-page: 50 year: 2013 ident: B18 article-title: Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis c infection publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-13-50 – volume: 21 start-page: 102922 year: 2022 ident: B51 article-title: Anti-rods/rings autoantibodies in a patient with pancreatic injury publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2021.102922 – volume: 56 year: 2018 ident: B10 article-title: Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications publication-title: Reumatologia doi: 10.5114/reum.2018.77976 – volume: 14 start-page: 89 year: 2021 ident: B19 article-title: Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies; literature first evidence publication-title: Gastroenterol Hepatol Bed Bench – volume: 12 start-page: 76 year: 2019 ident: B45 article-title: Primary biliary cholangitis with contemporary presence of anti-mithocondrial and anti-rods and rings autoantibodies: literature first case publication-title: Gastroenterol Hepatol Bed Bench – volume: 308 start-page: 35 year: 2014 ident: B15 article-title: Molecular cell biology and immunobiology of mammalian rod/ring structures publication-title: Int Rev Cell Mol Biol doi: 10.1016/B978-0-12-800097-7.00002-6 – volume: 21 year: 2001 ident: B42 article-title: Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis publication-title: Liver doi: 10.1034/j.1600-0676.2001.021004272.x – volume: 33 year: 2020 ident: B54 article-title: IMP dehydrogenase rod/ring structures in acral melanomas publication-title: Pigment Cell Melanoma Res doi: 10.1111/pcmr.12854 – volume: 7 start-page: e45392 year: 2012 ident: B24 article-title: Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-alpha publication-title: PloS One doi: 10.1371/journal.pone.0045392 – volume: 521 start-page: 199 year: 2021 ident: B44 article-title: Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer publication-title: Clin Chim Acta doi: 10.1016/j.cca.2021.07.006 – volume: 92 start-page: 87 year: 2019 ident: B34 article-title: Long-term antiviral hepatitis c treatment associated with rods and ring cytoplasmic antibodies publication-title: Med Pharm Rep doi: 10.15386/cjmed-996 – volume: 11 start-page: 8229 year: 2021 ident: B41 article-title: Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases publication-title: Sci Rep doi: 10.1038/s41598-021-87366-w – volume: 68 year: 2020 ident: B31 article-title: Anti-rod and ring antibodies in patients with chronic hepatitis c using direct-acting antivirals publication-title: Immunologic Res doi: 10.1007/s12026-020-09136-6 – volume: 22 year: 2016 ident: B32 article-title: Anti-rods/rings autoantibody generation in hepatitis c patients during interferon-alpha/ribavirin therapy publication-title: World J Gastroenterol doi: 10.3748/wjg.v22.i6.1966 – volume: 49 year: 2016 ident: B23 article-title: Clinical correlates of the “rods and rings” antinuclear antibody pattern publication-title: Autoimmunity doi: 10.3109/08916934.2015.1118762 – volume: 18 start-page: 102400 year: 2019 ident: B28 article-title: ANA as an entry criterion for the classification of SLE publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2019.102400 – volume: 21 year: 2014 ident: B35 article-title: Interferon-ribavirin therapy induces serum antibodies determining ‘rods and rings’ pattern in hepatitis c patients publication-title: J Viral Hepat doi: 10.1111/jvh.12281 – volume: 11 year: 2020 ident: B39 article-title: Anti-DFS70 antibodies among patient and healthy population cohorts in China: Results from a multicenter training program showing spontaneous abortion and pediatric systemic autoimmune rheumatic diseases are common in anti-DFS70 positive patients publication-title: Front Immunol doi: 10.3389/fimmu.2020.562138 – volume: 11 year: 2022 ident: B6 article-title: Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study publication-title: Cancer Med doi: 10.1002/cam4.4675 – volume: 6 year: 2015 ident: B13 article-title: Anti-Rods/Rings: A human model of drug-induced autoantibody generation publication-title: Front Immunol doi: 10.3389/fimmu.2015.00041 – volume: 42 year: 2015 ident: B17 article-title: Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction publication-title: J Genet Genomics doi: 10.1016/j.jgg.2015.04.002 – volume: 56 year: 2018 ident: B25 article-title: Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2017-1152 – volume: 65 year: 2021 ident: B33 article-title: The relevance between anti-rods/rings antibody and different treatment regimens in chronic hepatitis c virus infection publication-title: Microbiol Immunol doi: 10.1111/1348-0421.12879 – volume: 10 year: 2011 ident: B11 article-title: Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2011.06.005 – volume: 12 start-page: e0185977 year: 2017 ident: B40 article-title: Antinuclear antibodies and mortality in the national health and nutrition examination survey (1999-2004) publication-title: PloS One doi: 10.1371/journal.pone.0185977 – volume: 19 start-page: 102643 year: 2020 ident: B30 article-title: Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2020.102643 – volume: 412 year: 2011 ident: B47 article-title: Disease-specific autoantibodies in primary biliary cirrhosis publication-title: Clin Chim Acta doi: 10.1016/j.cca.2010.12.019 – volume: 52 year: 2020 ident: B9 article-title: Antinuclear antibodies in infectious diseases publication-title: Infect Dis (Lond) doi: 10.1080/23744235.2019.1690676 – volume: 33 year: 2013 ident: B20 article-title: Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients publication-title: J Clin Immunol doi: 10.1007/s10875-012-9827-4 – volume: 36 year: 2004 ident: B43 article-title: An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients publication-title: Transplant Proc doi: 10.1016/j.transproceed.2004.09.070 – volume: 173 year: 2016 ident: B22 article-title: Differential capacity of therapeutic drugs to induce Rods/Rings structures in vitro and in vivo and generation of anti-Rods/Rings autoantibodies publication-title: Clin Immunol doi: 10.1016/j.clim.2016.10.004 – volume: 32 year: 2019 ident: B36 article-title: Association of autoantibody to rods and rings with hepatitis c outcome and viral load publication-title: Viral Immunol doi: 10.1089/vim.2019.0012 – volume: 62 year: 2014 ident: B16 article-title: Ultrastructure of cytoplasmic and nuclear inosine-5’-monophosphate dehydrogenase 2 “rods and rings” inclusions publication-title: J Histochem Cytochem doi: 10.1369/0022155414543853 – volume: 60 start-page: 38 year: 2014 ident: B21 article-title: Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-alpha publication-title: Immunol Res doi: 10.1007/s12026-014-8515-2 – volume: 361 year: 2017 ident: B53 article-title: CTP synthase forms the cytoophidium in human hepatocellular carcinoma publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2017.10.030 – volume: 496 year: 2019 ident: B1 article-title: Anti-golgi antibodies: Prevalence and disease association in Chinese population publication-title: Clin Chim Acta doi: 10.1016/j.cca.2019.06.027 |
SSID | ssj0000493335 |
Score | 2.322535 |
Snippet | To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.ObjectiveTo investigate the distribution and... ObjectiveTo investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases.MethodsA total of 169,891 patients in... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 1007257 |
SubjectTerms | anti-nuclear antibody (ANA) anti‐rods/rings(anti-RR) autoimmune diseases (AIDs) hepatitis C Immunology prevalence |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlEOiltElLt0mDArkFk-i1snrbhoQlkJwSyE1IlkS37Npl10vIj8h_zozsDetLc8nN2DJ6zHjmG2v0DSEnBgyvT4oXLJSikEm5wkNkUYBv9wkQuRMKTyPf3I6n9_L6QT1slfrCnLCOHrhbuLMA72vudZK4Q2aSY9qPeZk0hzCQqQyNwOdtBVN_O9wrhFDdKRmIwsxZmi0Wa4gHOc-JARz90ZYnyoT9A5Q5zJHccjpXn8mnHi3SSTfKL-RDrPfIblc_8mmfPIOQ6eZsI0Xe7kibRHEbGg0ZxcHUTZqvm2VmbaoiBYxKwVJA9Ao-i8KyzgowoSu4ChR_8a3yPd9gcuEvOqHL2C6bzXFMmslosYv2saE4ZgCP0B3NVbi_kvury7uLadHXVygqKVVbRHUupDeChZQ8C6F0gE4Cr1IoxyCjJJiToQJM4IwOlZcVC5XBcuvRQFDtlfhGduqmjt8JBUkjVTzIBCGKD-48lU5rgEuByyDNiLDNWtuqJx_HGhhzC0EIysdm-ViUj-3lMyKnr-_866g3_tv6N4rwtSXSZucboEy2Vyb7ljKNyPFGASx8Zrh34urYrFcW5qZYacC6jYgeaMagx-GTevYnE3YbBSiXmR_vMcQD8hGnjSkrXB-SnXa5jj8BF7X-KH8CLx_nD3k priority: 102 providerName: Directory of Open Access Journals |
Title | The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China |
URI | https://www.proquest.com/docview/2725189870 https://pubmed.ncbi.nlm.nih.gov/PMC9552219 https://doaj.org/article/d4f572b7f478419fa17b628f72eb315a |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFA7riuCLeMXxskTwTaKbW9MIIqu4LsL65MC8laZJdJbZRjsddH-E_9lz0naxoIIvw0zaaS7n5JzvNMl3CHlqwfC6qAXjvpRMRV0zB5EFA9_uIiDyWmo8jXz6sThZqg8rvdojU7qjcQC3fwztMJ_Usts8__Ht4jVM-FcYcYK_fRHX5-c7CPWEyGv-oIRXyFXwTAYzGpyOcP9sQMNS5pybvCgUA11Wwzmavzxm5qsypf8Mh853Uf7mlo5vkhsjnqRHgwLcInuhvU2uDRkmL-6Qn6AGdDr9SJHZO9AUKS5Uo6mj2Jg2xc0udZnXqQkUUCwFWwLxLXg1CgO_ZmBkt_DNU3wJuM1lLuH2w5f0iHah79J0YJNmulqsov-eKLYZ4CVUR3Oe7rtkefzu09sTNmZgYI1SumdBH0rlrOQ-Rse9L2vAL1400ZcFSDFKXivfAGqorfGNUw33jcWE7MFC2O20vEf229SG-4SCLiCZvAgOQYzz9WEsa2MAUHmhvLILwqexrpqRnhyzZGwqCFNQPlWWT4XyqUb5LMizy_98Hcg5_nn3GxTh5Z1IrJ0LUve5Gudp5UFdjXAmKlyQtbHmxhWijNhwCf1ckCeTAlQwEXF1pW5D2m0r6JvmpQX7tyBmphmzGudX2vWXTOltNeBgbh_8V4cekuv4E3evCPOI7PfdLjwGiNS7g_xqAT7fr_hBngO_AEaME3c |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+clinical+value+of+indirect+immunofluorescence+for+screening+anti-rods+and+rings+antibodies%3A+A+retrospective+study+of+two+centers+in+China&rft.jtitle=Frontiers+in+immunology&rft.au=Meng%2C+Jingjing&rft.au=Yang%2C+Guoxiang&rft.au=Li%2C+Siting&rft.au=Luo%2C+Yueming&rft.date=2022-09-27&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=13&rft_id=info:doi/10.3389%2Ffimmu.2022.1007257&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2022_1007257 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |